Näytä suppeat kuvailutiedot

dc.contributor.authorKurki, Samu N.
dc.contributor.authorAla-Kurikka, Tommi
dc.contributor.authorLipponen, Arto
dc.contributor.authorPospelov, Alexey S.
dc.contributor.authorRolova, Taisia
dc.contributor.authorKoistinaho, Jari
dc.contributor.authorVoipio, Juha
dc.contributor.authorKaila, Kai
dc.date.accessioned2023-08-30T07:33:25Z
dc.date.available2023-08-30T07:33:25Z
dc.date.issued2023
dc.identifier.citationKurki, S. N., Ala-Kurikka, T., Lipponen, A., Pospelov, A. S., Rolova, T., Koistinaho, J., Voipio, J., & Kaila, K. (2023). A brain cytokine-independent switch in cortical activity marks the onset of sickness behavior triggered by acute peripheral inflammation. <i>Journal of Neuroinflammation</i>, <i>20</i>, Article 176. <a href="https://doi.org/10.1186/s12974-023-02851-5" target="_blank">https://doi.org/10.1186/s12974-023-02851-5</a>
dc.identifier.otherCONVID_184234550
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/88784
dc.description.abstractSystemic inflammation triggers protective as well as pro-inflammatory responses in the brain based on neuronal and/or cytokine signaling, and it associates with acutely and protractedly disrupted cognition. However, the multiple mechanisms underlying the peripheral–central inflammatory signaling are still not fully characterized. We used intraperitoneal (i.p.) injection of lipopolysaccharide (LPS) in freely moving mice with chronically implanted electrodes for recording of local field potentials (LFP) and electrocorticography (ECoG) in the hippocampus and neocortex, respectively. We show here that a sudden switch in the mode of network activity occurred in both areas starting at 10–15 min after the LPS injection, simultaneously with a robust change from exploration to sickness behavior. This switch in cortical mode commenced before any elevations in pro-inflammatory cytokines IL-1β, TNFα, CCL2 or IL-6 were detected in brain tissue. Thereafter, this mode dominated cortical activity for the recording period of 3 h, except for a partial and transient recovery around 40 min post-LPS. These effects were closely paralleled by changes in ECoG spectral entropy. Continuous recordings for up to 72 h showed a protracted attenuation in hippocampal activity, while neocortical activity recovered after 48 h. The acute sickness behavior recovered by 72 h post-LPS. Notably, urethane (1.3 mg/kg) administered prior to LPS blocked the early effect of LPS on cortical activity. However, experiments under urethane anesthesia which were started 24 h post-LPS (with neuroinflammation fully developed before application of urethane) showed that both theta–supratheta and fast gamma CA1 activity were reduced, DG delta activity was increased, and sharp-wave ripples were abolished. Finally, we observed that experimental compensation of inflammation-induced hypothermia 24–48 h post-LPS promoted seizures and status epilepticus; and that LPS decreased the threshold of kainate-provoked seizures beyond the duration of acute sickness behavior indicating post-acute inflammatory hyperexcitability. Taken together, the strikingly fast development and initial independence of brain cytokines of the LPS-induced cortical mode, its spectral characteristics and simultaneity in hippocampus and neocortex, as well as inhibition by pre-applied urethane, strongly suggest that the underlying mechanisms are based on activation of the afferent vagus nerve and its mainly cholinergic ascending projections to higher brain areas.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.ispartofseriesJournal of Neuroinflammation
dc.rightsCC BY 4.0
dc.titleA brain cytokine-independent switch in cortical activity marks the onset of sickness behavior triggered by acute peripheral inflammation
dc.typeresearch article
dc.identifier.urnURN:NBN:fi:jyu-202308304820
dc.contributor.laitosPsykologian laitosfi
dc.contributor.laitosDepartment of Psychologyen
dc.contributor.oppiainePsykologiafi
dc.contributor.oppiainePsychologyen
dc.type.urihttp://purl.org/eprint/type/JournalArticle
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.description.reviewstatuspeerReviewed
dc.relation.issn1742-2094
dc.relation.volume20
dc.type.versionpublishedVersion
dc.rights.copyright© The Author(s) 2023.
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysohippokampus
dc.subject.ysoaivokuori
dc.subject.ysoimmuunivaste
dc.subject.ysoneuroimmunologia
dc.subject.ysotulehdus
dc.subject.ysosytokiinit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p21117
jyx.subject.urihttp://www.yso.fi/onto/yso/p7039
jyx.subject.urihttp://www.yso.fi/onto/yso/p21599
jyx.subject.urihttp://www.yso.fi/onto/yso/p21971
jyx.subject.urihttp://www.yso.fi/onto/yso/p1049
jyx.subject.urihttp://www.yso.fi/onto/yso/p22729
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1186/s12974-023-02851-5
jyx.fundinginformationOpen Access funding provided by University of Helsinki including Helsinki University Central Hospital. This work was supported by grants from the Emil Aaltonen Foundation (SNK), The Finnish Medical Foundation (SNK), Päivikki and Sakari Sohlberg Foundation (SNK), The Finnish Brain Foundation (SNK) and the Sigrid Jusélius foundation (KK).
dc.type.okmA1


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot

CC BY 4.0
Ellei muuten mainita, aineiston lisenssi on CC BY 4.0